期刊文献+

代谢综合征与前列腺体积的相关性研究 被引量:2

Association between metabolic syndrome and prostate volume
原文传递
导出
摘要 目的探讨代谢综合征(MS)各相关指标与前列腺体积的相关性。方法采用随机数字法从健康查体的10056例中挑选30~49岁男性843例,测量患者血压、体质量、身高、腰围,并计算体质指数(BMI)。生化分析包括检测晨空腹血糖、总胆固醇、三酰甘油(TG)、高密度脂蛋白(HDL—c)、血前列腺特异抗原(PSA),并进行尿常规分析。采用直线回归分析评估MS及相关指标与前列腺体积的相关性。结果MS患者前列腺体积(28.3±5.5)ml明显大于对照组(23.2±5.6)ml(P%0.05),空腹血糖、收缩压、BMI、腰围异常组前列腺体积分别为(25.4±5.5)ml、(25.5±5.8)ml、(25.4±5.3)ml、(30.2±4.8)ml,亦大于对照组(23.6±5.5)ml、(23.4±5.4)ml、(22.6±5.5)ml、(23.5±5.3)ml(均P〈0.05)。前列腺体积与BMI、收缩压、腰围、空腹血糖、TG呈正相关(r=0.397、0.170、0.411、0.216、0.184,均P〈0.05),与HDL-C呈负相关(r=-0.107,P〈0.05)。结论MS各相关指标尤其是脂代谢紊乱、血压对前列腺的体积影响显著。 Objective To evaluate the relationship between parameters of MS and prostate volume. Methods A total of 843 men aged 30 to 49 years were enrolled from August 2008 to July 2011. Prostate volume by ultrasonography, serum prostate specific antigen, digital rectal examination, urinary analysis, and MS-related parameters were investigated. We evaluated the correlations of prostate volume with MS and MS components. Results Prostate volume was larger in the MS group (28.3±5.5 ml) than in the non-MS group (23.2±5.6 ml, P〈0.05). The prostate volumes in subjects with abnormal levels of fasting plasma glucose (FPG) (25.4±5.5 ml), body mass index (BMI) (25.4±5.3 ml) and waist circumference (30.2±4.8 ml) were increased compared with those of subjects with normal parameters (23.6±5.5 ml, 22.6±5.5 and 23.5±5.3 ml, respectively, all P〈0.05). The liner regression analysis showed that the FPG, BMI, WC, systolic pressure and triglyceride had a positive correlation with the prostate volume(r= 0. 216, 0. 397, 0. 411, 0. 170, 0.184, respectively; all P〈0.05),but negatively related to HDL-C(r=-0.107,P〈0.05). Conclusions The patients with abnormal FPG, BMI and waist circumference have larger prostate volume.
作者 盛斌武 马茂
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第11期935-937,共3页 Chinese Journal of Geriatrics
关键词 代谢综合征X 前列腺增生 Metabolic syndrome X Prostatic hyperplasia
  • 相关文献

参考文献7

  • 1Yim SJ,Cho YS,Joo KJ. Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age. Korean J Urol, 2011,52:390-395.
  • 2Moul S, Me Vary KT. Lower urinary tract symptoms,obesity and the metabolic syndrome. Curr Opin Urol,2010,20: 7-12.
  • 3Parsons JK, Carter HB. Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab,2006,91: 2562-2568.
  • 4Parsons JK, Sarma AV, McVary K, et al. Obesity and benign prostatic hyperplasia; clinical connections, emerging etiological paradigms and future directions. J Urol, 2009,182 ( Suppl 6 ): S27-31.
  • 5Sarma AV, Kellogg Parsons J. Diabetes and benign prostatic hyperplasia: emerging clinical connections. Curr Urol Rep, 2009,10:267-275.
  • 6Ozden C, Ozdal OL,Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol, 2007 , 51 ; 199-203.
  • 7曹彬,孙宏斌,苏江浩,沈明顺,曹志刚,贾瑞鹏,刘军.代谢综合征与良性前列腺增生症临床进展的相关性[J].中华医学杂志,2010,90(40):2823-2825. 被引量:12

二级参考文献14

  • 1郭利君,张祥华,李培军,那彦群.良性前列腺增生与原发性高血压的相关性研究[J].中华外科杂志,2005,43(2):108-111. 被引量:59
  • 2郭利君,张祥华,李培军,那彦群.高血压对良性前列腺增生组织中血管新生影响的研究[J].中华医学杂志,2005,85(9):606-609. 被引量:30
  • 3李培军,张祥华,郭利君,那彦群.高脂血症与良性前列腺增生相关性的临床研究[J].中华外科杂志,2005,43(6):387-389. 被引量:33
  • 4宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:620
  • 5Rohrmann S,Platz EA,Giovannucci E,et al.Lifestyle and benign prostatic hyperplasia in older men:what do we know?Men's Health Gender,2005,2:230-235.
  • 6Kristal AR,Arnold KB,Schenk JM,et al.Race/ ethnicity,obesity,health related behaviors and the risk of symptomatic benign prostatic hyperplasia:results from the prostate cancer prevention trial.J Urol,2007,177:1395-1400.
  • 7Lee S,Min HG,Choi SH,et al.Central obesity as a risk factor for prostatic hyperplasia.Obesity,2006,14:172-179.
  • 8Dahle SE,Chokkalingam AP,Gao YT,et al.Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.J Urol,2002,168:599-604.
  • 9Hammarsten J,Hogstedt B.Hyper-insulinaemia as a risk factor for developing benign prostatic hyperplasia.Eur Urol,2001,39:151-158.
  • 10Ozden C,Ozdal QL,Hakan K,et al.The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.Eur Urol,2007,51:199-203.

共引文献11

同被引文献9

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部